Clinical Trial Update: ALTROPANE® SPECT Imaging in Patients With Parkinson Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ALTROPANE SPECT imaging in patients with Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Altropane (Altropane)

Snippet

Sponsor: Molecular NeuroImaging | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED